mesoridazine has been researched along with haloperidol in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (53.85) | 18.7374 |
| 1990's | 1 (3.85) | 18.2507 |
| 2000's | 6 (23.08) | 29.6817 |
| 2010's | 5 (19.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keserü, GM | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Jia, L; Sun, H | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Giordanetto, F; Leach, AG; Zachariae, U | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Sen, S; Sinha, N | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, X; Ding, HF; Lang, L; Liu, G; Sun, SY; Yan, C | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Korenyl, C; Rosfnfeld, C; Weitzman, DO; Whittier, JR | 1 |
| Busk, J; Eaton, EM; Maloney, MP; Sloane, RB; Whipple, K; White, K | 1 |
| Swett, C | 1 |
| Berens, K; Cleary, J; Poling, A; Thompson, T | 1 |
| Millichamp, CJ; Singh, NN | 1 |
| Greendyke, RM; Kanter, DR | 1 |
| Birnbaum, D; Karmeli, F | 1 |
| Palestine, ML | 1 |
| Lal, S; Sourkes, TL | 1 |
| Auvinen, J; Linnolia, M; Vaisanen, K; Viukari, M | 1 |
| Busk, J; Eaton, E; Gomez, G; Razani, J; Sloane, RB; White, K | 1 |
| Auvinen, J; Linnoila, M; Vaisanen, K; Viukari, M | 1 |
| Breuning, SE; Davidson, NA | 1 |
| Räisänen, P; Rimón, R; Väisänen, K; Viukari, M | 1 |
| Korenyi, C; Whittier, JR | 1 |
2 review(s) available for mesoridazine and haloperidol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacological treatment of self-injurious behavior in mentally retarded persons.
Topics: Adolescent; Anti-Anxiety Agents; Antipsychotic Agents; Butyrophenones; Chlorpromazine; Double-Blind Method; Female; Haloperidol; Humans; Intellectual Disability; Lithium; Lithium Carbonate; Male; Mesoridazine; Methylphenidate; Phenothiazines; Psychotropic Drugs; Reserpine; Self Mutilation; Thioridazine | 1985 |
4 trial(s) available for mesoridazine and haloperidol
| Article | Year |
|---|---|
Hemispheric dysfunction in schizophrenia: assessment by visual perception tasks.
Topics: Acute Disease; Adult; Cerebral Cortex; Dominance, Cerebral; Double-Blind Method; Female; Haloperidol; Humans; Male; Mesoridazine; Schizophrenia; Visual Perception | 1979 |
Drug treatment of the alcohol withdrawal syndrome and delirium tremens. A comparison of haloperidol with mesoridazine and hydroxyzine.
Topics: Adult; Aged; Alcoholism; Clinical Trials as Topic; Female; Haloperidol; Humans; Hydroxyzine; Injections, Intramuscular; Male; Mesoridazine; Middle Aged; Physical Examination; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Psychoses, Alcoholic; Substance Withdrawal Syndrome | 1973 |
Dysphoric response to neuroleptics as a predictor of treatment outcome with schizophrenics. A comparative study of haloperidol versus mesoridazine.
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Double-Blind Method; Emotions; Female; Haloperidol; Humans; Male; Mesoridazine; Psychiatric Status Rating Scales; Schizophrenia | 1981 |
Haloperidol, thioridazine and placebo in mentally subnormal patients-serum levels and clinical effects.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Haloperidol; Humans; Intellectual Disability; Male; Mesoridazine; Middle Aged; Placebos; Psychomotor Agitation; Random Allocation; Thioridazine | 1981 |
20 other study(ies) available for mesoridazine and haloperidol
| Article | Year |
|---|---|
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.
Topics: Binding Sites; Ether-A-Go-Go Potassium Channels; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Potassium Channel Blockers; Protein Binding; Protein Conformation | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
Topics: CRISPR-Cas Systems; Gene Targeting; Genes; Genes, Reporter; Genetic Engineering; Humans; Internal Ribosome Entry Sites; Transcription, Genetic | 2015 |
Quantification of chorea in Huntington's disease by power spectral analysis.
Topics: Adult; Aged; Diazepam; Haloperidol; Humans; Huntington Disease; Mesoridazine; Methods; Middle Aged; Movement Disorders; Prochlorperazine; Time Factors; Trihexyphenidyl | 1976 |
Drug-induced dystonia.
Topics: Adjustment Disorders; Adult; Basal Ganglia Diseases; Chlorpromazine; Chlorprothixene; Female; Fluphenazine; Haloperidol; Humans; Male; Mental Disorders; Mesoridazine; Middle Aged; Perphenazine; Psychotic Disorders; Psychotropic Drugs; Schizophrenia; Thioridazine; Thiothixene; Trifluoperazine | 1975 |
Neuroleptics and learning: effects of haloperidol, molindone, mesoridazine and thioridazine on the behavior of pigeons under a repeated acquisition procedure.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Chlorpromazine; Columbidae; Dose-Response Relationship, Drug; Haloperidol; Learning; Male; Mesoridazine; Molindone; Thioridazine | 1990 |
Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations.
Topics: Adult; Aged; Drug Interactions; Haloperidol; Humans; Male; Mesoridazine; Middle Aged; Neurocognitive Disorders; Phenothiazines; Propranolol; Thioridazine | 1987 |
The effect of psychopharmaca on uropeptic activity.
Topics: Animals; Depression, Chemical; Diazepam; Dibenzothiazepines; Endopeptidases; Haloperidol; Humans; Male; Mesoridazine; Oxazepam; Peptic Ulcer; Rats; Secretory Rate | 1974 |
Potentiation and inhibition of the amphetamine stereotypy in rats by neuroleptics and other agents.
Topics: Animals; Behavior, Animal; Chlorpromazine; Chlorprothixene; Compulsive Behavior; Dexamethasone; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Drug Synergism; Haloperidol; Humans; Lithium; Male; Mesoridazine; Methotrimeprazine; Motor Activity; Prochlorperazine; Promazine; Promethazine; Quinine; Rats; Tranquilizing Agents; Triflupromazine; Warfarin | 1972 |
Plasma neuroleptic and prolactin levels in mentally retarded patients.
Topics: Antipsychotic Agents; Female; Haloperidol; Humans; Intellectual Disability; Male; Mesoridazine; Prolactin; Thioridazine | 1980 |
Effect of anticonvulsants on plasma haloperidol and thioridazine levels.
Topics: Adult; Drug Therapy, Combination; Epilepsy, Tonic-Clonic; Female; Haloperidol; Humans; Intellectual Disability; Male; Mesoridazine; Phenobarbital; Phenytoin; Thioridazine | 1980 |
Effects of psychotropic drugs on intelligence test performance of institutionalized mentally retarded adults.
Topics: Adult; Chlorpromazine; Female; Haloperidol; Humans; Intellectual Disability; Intelligence Tests; Lithium; Lithium Carbonate; Male; Mesoridazine; Middle Aged; Psychotropic Drugs; Thioridazine | 1981 |
Dyskinesia analysis. Histogram analysis of cineseismograms of human dyskinesia.
Topics: Aged; Anti-Dyskinesia Agents; Dyskinesias; Haloperidol; Humans; Huntington Disease; Male; Mesoridazine; Middle Aged; Motion Pictures; Neurology; Prochlorperazine; Retreatment; Severity of Illness Index; Treatment Outcome | 1974 |